Occurrence of trazodone-induced delirium

International Clinical Psychopharmacology

Volumn 13, Issue 5, 1998, Pages 225-228

  Lennkh, C ^a   Fischer, P ^a   Kufferle B ^a   Kasper, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Serotonin syndrome; Trazodone induced delirium

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; SEROTONIN ANTAGONIST; TRAZODONE;

ADULT; AGITATION; ARTICLE; BRAIN INJURY; CASE REPORT; COGNITIVE DEFECT; DELIRIUM; DEPRESSION; FEMALE; HALLUCINATION; HUMAN; PRIORITY JOURNAL; THYROID DISEASE;

EID: 0031658189     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199809000-00006     Document Type: Article

References (20)

1. Beasley C, Dornseif B, Pultz S (1990): Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry 52, 295-299.
2. Brogden RN, Heel RB, Speight TM, Avery GS (1981): Trazodone: a review of its pharmacologic properties and therapeutic use in depression and anxiety. Drugs 21, 401-429.
3. Caccia S, Ballabio M, Zanini MG, Garatlini S (1981): M-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol, 33, 477-478.
4. Damlouji N, Ferguson J (1984): Trazodone-induced delirium in bulimic patients. Am J Psychiatry 141, 434-435.
5. Fischer P (1995): Serotonin syndrome in the elderly after antidepressive monotherapy. J Clin Psychopharmacol 15:440-442.
6. Gerner R, Estabrook W, Steuer J, Jarvik L (1980): Treatment of geriatric depression with trazodone, imipramine, and placebo. J Clin Psychiatry 41, 216-220.
7. Gershon S, Mann J, Newton R, Gunther BJ (1981): Evaluation of trazodone in the treatment of endogenous depression: results of a multicenter double blind study. J Clin Psychopharmacol 1 (Suppl. 6), 39S-44S.
8. Haria M, Fitton A, McTavish D (1994): Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 4, 331-355.
9. Lawlor BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL (1991): A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers. Biol Psychiatry 29, 281-286.
10. Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL (1989): Hyperresponsitivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. Arch Gen Psychiatry 46, 542-549.
11. Levitan RD, Kaplan AS, Brown GM, Brenan GM, Vaccarino FJ, Kenedy SH, et al. (1998): Hormonal and subjective responses to intravenious m-chlorophenylpiperazine in women with seasonal affective disorder. Arch Gen Psychiatry 55, 244-249.
12. Livingston R, Zucker D, Isenberg K, Wetzel RD (1983): Tricyclic antidepressants and delirium. J Clin Psychiatry 44, 173-176.
13. Moises HW, Kasper S, Beckmann H (1981): Trazodone and amitriptyline in the treatment of depressed inpatients. Pharmacopsychiatry 14, 167-171.
14. Mueller EA, Murphy DL, Sunderland T (1986): Further studies of the putative serotonin agonist, m-chlorphenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89, 388-391.
15. Peroutka SJ (1995): 5-HT receptors: past, present, future. Trends Neurosci 18, 68-69.
16. Rao R (1997): Serotonin syndrome associated with trazodone. Int J Geriatr Psychiatry 12, 129-132.
17. Risch S, Janowsky D (1981): Trazodone. Psychiatr Ann 11, 47-55.
18. Saarma J (1974): Trazodone: a review of literature. In: Modern problems in pharmacology. Vol. 9. (TA Ban, B Silvestrini, eds). Basel: S Karger.
19. Sternbach H (1991): The serotonin syndrome. Am J Psychiatry 148, 705-713.
20. Warren M, Bick P (1984): Two case reports of trazodone-induced mania. Am J Psychiatry 141, 1103-1104.